Variant angina associated with bitter orange in a dietary supplement.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16610576.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Food and Drug Administration has banned the sale of ephedrine-based weight-loss products because of their association with many cardiovascular adverse effects. Bitter orange is now being used as a stimulant in "ephedra-free" weight-loss supplements but was recently implicated in adverse cardiovascular sequelae. To our knowledge, this report describes the first case of variant angina associated with bitter orange in a dietary supplement.
Medical subject headings
- Angina Pectoris, Variant
- Dietary Supplements
- Synephrine
- Vasoconstrictor Agents